Author:
Junli Zhang,Shuhan Wang,Yajuan Zhao,Xiaoling Deng,Jiahuan Li,Keshu Xu
Funder
National Natural Science Foundation of China
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference50 articles.
1. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020
2. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages;Liu;Biomed. Pharmacother.,2020
3. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies;Stefan;Lancet Diabetes Endocrinol.,2019
4. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, nature reviews;Younossi;Gastroenterol. Hepatol.,2018
5. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis;Li;Lancet Gastroenterol. Hepatol.,2019
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献